IQVIA Holdings stock surged on Tuesday after the clinical research and analytics company's second-quarter results topped ...

Shares of IQVIA Holdings Inc. IQV slipped 2.97% to $185.86 Thursday, on what proved to be an all-around rough trading session ...

We recently published 10 Stocks with Surprising Gains. IQVIA Holdings Inc. (NYSE:IQV) is one of Tuesday’s top performers.

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article ...

IQVIA Holdings Inc. (NYSE:IQV), a global leader in advanced analytics, technology solutions, and clinical research services for the healthcare and life sciences industries, finds itself at a ...

IQVIA Holdings Inc.'s Q1 results highlighted strong profitability, robust TAS growth, and a healthy backlog. Click here to read an analysis of IQV stock now.

Analysts have recently evaluated IQVIA Hldgs and provided 12-month price targets. The average target is $177.67, accompanied by a high estimate of $196.00 and a low estimate of $160.00. Experiencing a ...

I rate IQVIA as a hold due to long-term competitive threats, particularly from one player, and concerns about capital allocation and high debt. IQVIA's business model is solid, but declining gross ...

IQVIA Holdings stock surged on Tuesday after the clinical research and analytics company's second-quarter results topped estimates.

Second Quarter 2025 Results Key Financial Results Revenue: US$4.02b (up 5.3% from 2Q ...

Detailed price information for Iqvia Holdings Inc (IQV-N) from The Globe and Mail including charting and trades.